Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:26 AM
Ignite Modification Date:
2025-12-25 @ 12:26 AM
NCT ID:
NCT06392958
Eligibility Criteria:
Inclusion Criteria:
* (1) All met the diagnostic criteria for coronary heart disease;
* (2) PCI was performed for the first time with clear indications of PCI surgery;
* (3) Postoperative condition was stable;
* (4) NYHA cardiac function grade I-II;
* (5) Age 60 \~75 years old;
* (6) Patients and their family members gave informed consent to this study and signed informed consent, which met the ethical standards of human trials and was approved by the ethics committee of the hospital.
Exclusion Criteria:
* (1) Uncontrolled arrhythmias combined with hemodynamic abnormalities.
* (2) COPD, pulmonary embolism, deep vein thrombosis, stroke and other factors affecting motor function.
* (3) Physical disability affecting safety and full participation in the experiment.
* (4) myocarditis, cardiomyopathy, liver and kidney insufficiency.
* (5) Aphasia, hearing impairment and other conditions affecting normal doctor-patient communication.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
60 Years
Maximum Age:
75 Years
Study:
NCT06392958
Study Brief:
Protocol Section:
NCT06392958